User:Oddvector/Seroconversion/Bibliography

Bibliography

edit

Seroconversion sources thus far

Definition

  • Sources for the defintions of seroconversion,[1] window period (which does not have a source for its definition),[2] and false negative.[3]

Symptoms: This article currently lacks information about the symptoms of seroconversion for HIV and experience of the seroconversion period.

  • Overview of symptoms[4]
  • More detailed information[5]

Additional information: seroconversion has farther reaching implications than those listed in this article

  • Seroconversion's clinically relevant usage in detecting Kaposi sarcoma early for HIV patients[6]
  • Seroconversion with respect to maternal antibodies and its impact on vaccination[7]

Mechanism of seroconversion: the mechanism section on the page currently has zero sources.

  • Information about seroconversion in COVID-19[8]
  • Basic explanation of seroconversion mechanism[9]
  • Mechanism of antibody-antigen binding[10]

COVID-19 specific information: more COVID-19 specific information has arisen since the article was last updated, which may be of relevant information to persons checking the page for understanding of the pandemic.

  • Asymptomatic seroconversion,[11] to better differentiate from HIV-related seroconversion
  • Differentiation of pathophysiology of COVID-19 based on seroconversion,[12] with possible differences in therapy
  • Seroconversion from the COVID-19 vaccine[13]
  • Differences in seroconversion in different populations[14]
  • Factors leading to nonseroconversion[15]


  1. ^ "Seroconversion | NIH". clinicalinfo.hiv.gov. Retrieved 2021-11-01.
  2. ^ "Window Period | NIH". clinicalinfo.hiv.gov. Retrieved 2021-11-01.
  3. ^ "False Negative | NIH". clinicalinfo.hiv.gov. Retrieved 2021-11-01.
  4. ^ "Symptoms and seroconversion | Guides | HIV i-Base". i-base.info. Retrieved 2021-11-01.
  5. ^ Hirschel, Bernard (2017-01-01), Cohen, Jonathan; Powderly, William G.; Opal, Steven M. (eds.), "93 - Primary HIV Infection", Infectious Diseases (Fourth Edition), Elsevier, pp. 846–849.e1, doi:10.1016/b978-0-7020-6285-8.00093-9, ISBN 978-0-7020-6285-8, retrieved 2021-11-01
  6. ^ Renwick, N.; Halaby, T.; Weverling, G. J.; Dukers, N. H.; Simpson, G. R.; Coutinho, R. A.; Lange, J. M.; Schulz, T. F.; Goudsmit, J. (1998-12-24). "Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma". AIDS (London, England). 12 (18): 2481–2488. doi:10.1097/00002030-199818000-00018. ISSN 0269-9370. PMID 9875587.
  7. ^ Siegrist, C (2003-07-28). "Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants". Vaccine. 21 (24): 3406–3412. doi:10.1016/S0264-410X(03)00342-6.
  8. ^ "COVID-19 Serology Testing Explained". ASM.org. Retrieved 2021-11-01.
  9. ^ "The Immune Response against Pathogens | Anatomy and Physiology". courses.lumenlearning.com. Retrieved 2021-11-01.
  10. ^ van Oss, C. J.; Good, R. J.; Chaudhury, M. K. (1986-04-11). "Nature of the antigen-antibody interaction. Primary and secondary bonds: optimal conditions for association and dissociation". Journal of Chromatography. 376: 111–119. PMID 3711190.
  11. ^ Hains, David S.; Schwaderer, Andrew L.; Carroll, Aaron E.; Starr, Michelle C.; Wilson, Amy C.; Amanat, Fatima; Krammer, Florian (2020-06-16). "Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit". JAMA. 323 (23): 2424. doi:10.1001/jama.2020.8438. ISSN 0098-7484. PMC 7226282. PMID 32407440.{{cite journal}}: CS1 maint: PMC format (link)
  12. ^ Galbraith, Matthew D; Kinning, Kohl T; Sullivan, Kelly D; Baxter, Ryan; Araya, Paula; Jordan, Kimberly R; Russell, Seth; Smith, Keith P; Granrath, Ross E; Shaw, Jessica R; Dzieciatkowska, Monika (2021-03-16). Schoggins, John W; Sawyer, Sara L; Khor, Bernard (eds.). "Seroconversion stages COVID19 into distinct pathophysiological states". eLife. 10: e65508. doi:10.7554/eLife.65508. ISSN 2050-084X.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  13. ^ Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M.; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian (2021-01-19). "COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses". Nature. 586 (7830): 594–599. doi:10.1038/s41586-020-2814-7. ISSN 1476-4687.
  14. ^ Soytas, Rabia Bag; Cengiz, Mahir; Islamoglu, Mehmet Sami; Uysal, Betul Borku; Ikitimur, Hande; Yavuzer, Hakan; Yavuzer, Serap (2021). "Does the COVID-19 seroconversion in older adults resemble the young?". Journal of Medical Virology. 93 (10): 5777–5782. doi:10.1002/jmv.27106. ISSN 1096-9071. PMC 8242906. PMID 34042191.{{cite journal}}: CS1 maint: PMC format (link)
  15. ^ Liu, Weimin; Russell, Ronnie M.; Bibollet-Ruche, Frederic; Skelly, Ashwin N.; Sherrill-Mix, Scott; Freeman, Drew A.; Stoltz, Regina; Lindemuth, Emily; Lee, Fang-Hua; Sterrett, Sarah; Bar, Katharine J. "Predictors of Nonseroconversion after SARS-CoV-2 Infection - Volume 27, Number 9—September 2021 - Emerging Infectious Diseases journal - CDC". doi:10.3201/eid2709.211042. {{cite journal}}: Cite journal requires |journal= (help)